Back to state act
Description
On 1 December 2025, the UK Government announced a pharmaceuticals agreement with the United States under the UK–US Economic Prosperity Deal. As part of the agreement, the UK made commitments that will...
Sign in or create a free account to see full description
Intervention Details
Intervention Type
Instrument unclear
MAST Chapter
Instrument unclear
Implementation date
No implementation date
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 22 products
Threads
See all
United States: Drug Pricing Agreements
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
68
interventions
2
jurisdictions
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70711
interventions
194
jurisdictions